ArticleBJUI compass2026
Oncological outcomes post focal low-dose-rate brachytherapy in low-intermediate risk prostate cancer.
Mohammadmehdi Adhami et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it